Open AccessDevelopment of Novel Isoindolone‐Based Compounds against Trypanosoma brucei rhodesiense
Author(s) -
Silva Daniel G.,
Feijens PimBart,
Hendrickx Rik,
Matheeussen An,
Grey Lucie,
Caljon Guy,
Maes Louis,
Emery Flavio S.,
Junker Anna
Publication year - 2021
Publication title -
chemistryopen
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.644
H-Index - 29
ISSN - 2191-1363
DOI - 10.1002/open.202100180
Subject(s) - trypanosoma brucei rhodesiense , chemistry , cytotoxicity , trypanosoma brucei , potency , in vitro , in vivo , ic50 , trypanocidal agent , structure–activity relationship , trypanosoma cruzi , leishmania infantum , biochemistry , stereochemistry , combinatorial chemistry , leishmania , biology , parasite hosting , microbiology and biotechnology , world wide web , computer science , gene
Abstract This study identified the isoindolone ring as a scaffold for novel agents against Trypanosoma brucei rhodesiense and explored the structure‐activity relationships of various aromatic ring substitutions. The compounds were evaluated in an integrated in vitro screen. Eight compounds exhibited selective activity against T. b. rhodesiense (IC 50 <2.2 μ m ) with no detectable side activity against T. cruzi and Leishmania infantum . Compound 20 showed low nanomolar potency against T. b. rhodesiense (IC 50 =40 n m ) and no toxicity against MRC‐5 and PMM cell lines and may be regarded as a new lead template for agents against T. b. rhodesiense . The isoindolone‐based compounds have the potential to progress into lead optimization in view of their highly selective in vitro potency, absence of cytotoxicity and acceptable metabolic stability. However, the solubility of the compounds represents a limiting factor that should be addressed to improve the physicochemical properties that are required to proceed further in the development of in vivo‐active derivatives.